7347-35-5

Basic information

• Product Name: N-(2-aminoethyl)ethylenediamine acetate
• Synonyms: N-(2-aminoethyl)ethylenediamine acetate
• CAS NO: 7347-35-5
• Molecular Formula: C6H17N3O2
• Molecular Weight: 163.21808
• EINECS: 230-877-7
• Mol File: 7347-35-5.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 353.2°C at 760 mmHg
• Flash Point: 167.4°C
• Appearance: /
• Vapor Pressure: 6.17E-06mmHg at 25°C
• CAS DataBase Reference: N-(2-aminoethyl)ethylenediamine acetate(CAS DataBase Reference)
• NIST Chemistry Reference: N-(2-aminoethyl)ethylenediamine acetate(7347-35-5)
• EPA Substance Registry System: N-(2-aminoethyl)ethylenediamine acetate(7347-35-5)

Safety Data

• Hazardous Substances Data: 7347-35-5(Hazardous Substances Data)

Usage

InChI:InChI=1/C4H13N3.C2H4O2/c5-1-3-7-4-2-6;1-2(3)4/h7H,1-6H2;1H3,(H,3,4)

Relevant articles and documents

Preventing and/or treating cardiovascular disease and/or associated heart failure

Methods are provided for reducing copper values for, by way of example, treating, preventing or ameliorating tissue damage such as, for example, tissue damage that may be caused by (i) disorders of the heart muscle (for example, cardiomyopathy or myocarditis) such as idiopathic cardiomyopathy, metabolic cardiomyopathy which includes diabetic cardiomyopathy, alcoholic cardiomyopathy, drug-induced cardiomyopathy, ischemic cardiomyopathy, and hypertensive cardiomyopathy, (ii) atheromatous disorders of the major blood vessels (macrovascular disease) such as the aorta, the coronary arteries, the carotid arteries, the cerebrovascular arteries, the renal arteries, the iliac arteries, the femoral arteries, and the popliteal arteries, (iii) toxic, drug-induced, and metabolic (including hypertensive and/or diabetic disorders of small blood vessels (microvascular disease) such as the retinal arterioles, the glomerular arterioles, the vasa nervorum, cardiac arterioles, and associated capillary beds of the eye, the kidney, the heart, and the central and peripheral nervous systems, (iv) plaque rupture of atheromatous lesions of major blood vessels such as the aorta, the coronary arteries, the carotid arteries, the cerebrovascular arteries, the renal arteries, the iliac arteries, the fermoral arteries and the popliteal arteries, (v) diabetes or the complications of diabetes.

Polypeptide derivatives

A biologically active peptide selected from growth factors, peptide hormones, interferons and cytokines and analogues and derivatives thereof, and bearing at least one chelating group linked to an amino group of said peptide, the chelating group being capable of complexing a detectable element and such amino group having no significant binding affinity to target receptors, are complexed with a detectable element and are useful as a pharmaceutical, e.g. a radiopharmaceutical for in vivo imaging of target tissues or for therapy.